Mesoblast Limited reported $7.7M of revenue over the trailing twelve months, −24% on the year before. 6 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $7.7M (to Q4 2023). Net Income: −$82M, trailing twelve months to Q4 2023. EPS: −$0.11, trailing twelve months to Q4 2023.

MESOMesoblast Limited

HealthcareUSD

$16.83

$12.8852 weeks$20.96

MESO as reported

Mesoblast Limited reported $7.7M of revenue over the trailing twelve months, −24% on the year before. 6 reported series are charted on this page, each one as filed.

$7.7M

Revenue, trailing twelve months · to Q4 2023 · −24% against the twelve months before

Net Income: −$82M
Net Income · −10% year on year · trailing twelve months to Q4 2023
EPS: −$0.11
EPS · −21% year on year · trailing twelve months to Q4 2023